Guloy, Casan M.
HRN: 08-55-98 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/29/2025
CEFTAZIDIME 1GM (VIAL)
05/29/2025
06/04/2025
IV
1g
Q8h
Cap-Mr
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes